Skip to content

SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography

SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by Ultrasonography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02170233
Enrollment
65
Registered
2014-06-23
Start date
2014-08-31
Completion date
2016-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

The study aim is to examine point-of-care ultrasound findings, reliability, and ease of performance in association with fluid responsiveness for patients with severe sepsis and septic shock. The investigators propose a prospective observational research study of patients presenting to one of three Yale New Haven Hospital emergency departments, York Street Campus, St. Raphael's Campus, and Shoreline Medical Center who meet criteria for sepsis, severe sepsis or septic shock during their emergency department visit.

Detailed description

After each 1 Liter fluid challenge of IV fluid each outcome measure will be repeated to determine if there is a change in ultrasound measures as patients undergo volume resuscitation.

Interventions

None listed

Sponsors

Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients age greater than 18 years who meet criteria of sepsis. Septic shock will be defined as those patients with severe sepsis and persistent hypotension (\<90mmHg systolic blood pressure) despite a fluid challenge of at least 20cc/kg * Patients will only be considered eligible for enrollment if the treating physician plans to give at least 1-liter of crystalloid after initial US is performed * A number (approximately 50 patients) with no symptoms of sepsis will be enrolled to assess measurements in healthy patients. These patients will only have one ultrasound performed for each of the desired study measures.

Exclusion criteria

* Patients unable to provide consent such as non-English speaking patients or patient/health care proxy unable to give consent * History of significant trauma * Incarcerated patients * Failure to complete fluid challenge * Pericardial disease or heart transplant. Patients with left bundle branch block, pulmonary hypertension, known systolic dysfunction (Ejection Fraction \<40%), receiving vasopressors, known moderate or severe valvular dysfunction, and irregular heart rhythms will be enrolled but analyzed separately

Design outcomes

Primary

MeasureTime frameDescription
Fluid responsiveness as defined by 15% increase in cardiac output in response to 1 liter of IV fluidparticipants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: Carotid corrected flow time in relation to cardiac output to assess fluid responsiveness.

Secondary

MeasureTime frameDescription
Early (E') septal left ventricular filling velocity as measured by ultrasoundparticipants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: Early (E') septal left ventricular filling velocity by tissue Doppler in relation to cardiac output to assess fluid responsiveness.
Late (A') septal left ventricular filling velocity as measured by ultrasoundparticipants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measure: Late (A') septal left ventricular filling velocity by Tissue Doppler in relation to cardiac output to assess fluid responsiveness.
Respirophasic carotid velocity (ΔVpeak) as measured by ultrasound in relation to cardiac output to assess fluid responsiveness.participants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measure: Respirophasic carotid velocity (ΔVpeak) in relation to cardiac output to assess fluid responsiveness.
Fluid volume measurement as measured by ultrasoundparticipants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: IVC diameter in relation to cardiac output to assess fluid responsiveness.
Late (A) mitral inflow velocity in relation to cardiac output to assess fluid responsiveness as measured by ultrasound.participants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: Late (A) mitral inflow velocity in relation to cardiac output to assess fluid responsiveness.
Carotid velocity-time integral in relation to cardiac output to assess fluid responsiveness as measured by ultrasound.participants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: Carotid velocity-time integral in relation to cardiac output to assess fluid responsiveness.
Early (E) mitral inflow velocity in relation to cardiac output to assess fluid responsiveness as measured by ultrasound.participants will be followed for the duration of their emergency department stay, an expected average of 6 hoursUltrasound Measurement: Early (E) mitral inflow velocity in relation to cardiac output to assess fluid responsiveness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026